MicroRNA-223 affects IL-6 secretion in mast cells via the IGF1R/PI3K signaling pathway

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Interleukin-6 (IL-6) is a key cytokine involved in inflammatory responses.
• Mast cells play a crucial role in allergic reactions and inflammation.
• MicroRNAs (miRNAs) are emerging as critical regulators of cellular processes, including immune responses.

Purpose of the Study:

• To investigate the role of microRNA-223 (miR-223) in regulating IL-6 secretion from mast cells.
• To elucidate the molecular mechanisms by which miR-223 influences IL-6 production.
• To identify the specific signaling pathways targeted by miR-223 in mast cells.

Main Methods:

• Mast cells (P815) were transfected with miR-223 lentiviral vectors and inhibitors.
• Reverse transcription-quantitative PCR (RT-qPCR) was used to assess miR-223 expression.
• Enzyme-linked immunosorbent assay (ELISA) measured IL-6 levels.
• Gene chip analysis, luciferase reporter assays, and western blotting identified signaling pathways and target genes.
• Pharmacological inhibitors (LY294002) and ligands (IGF1) were employed to validate pathway involvement.

Main Results:

• Downregulation of miR-223 led to increased IL-6 secretion in mast cells.
• The PI3K-AKT signaling pathway was identified as a key mediator.
• Luciferase assays confirmed insulin-like growth factor-1 receptor (IGF1R) as a direct target of miR-223.
• Increased levels of phosphorylated AKT (p-AKT) and IGF1R were observed upon miR-223 inhibition.
• Inhibition of PI3K signaling reduced IL-6 secretion, while IGF1 stimulation enhanced it.

Conclusions:

• MicroRNA-223 plays an inhibitory role in IL-6 secretion by mast cells.
• miR-223 exerts its function by targeting and suppressing the IGF1R/PI3K/AKT signaling pathway.
• These findings highlight miR-223 as a potential therapeutic target for modulating mast cell-mediated inflammation.